News
News from us and our partners
News
Crossover
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Tags
Topics
0 results
- News
Bio-engineering scale-up Qorium showcases cultivated leather breakthrough, signalling a key step towards commercialisation
- News
Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study
- News
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
- News
Pi-Cardia receives FDA market clearance for ShortCut™
- News
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
- News
Sensorion reports new positive clinical results presented at the World Congress of Audiology
- News
Arzeda secures $38M in oversubscribed funding round to advance protein design commercialization efforts
- News
AAVantgarde announces first patient dosed with AAVB-081 in FIH Phase 1/2 LUCE-1 study for retinitis pigmentosa related to USH1B
- News
F2G announces $100 million financing to advance late-stage development and commercialization of novel antifungal drug candidate Olorofim in the US
- News
Novameat raises €17.4M oversubscribed Series A round led by Sofinnova Partners and Forbion
- News
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
- News
Sofinnova Partners appoints Karl Naegler as Partner
- News
AAVantgarde appoints Dr. Jayashree Sahni as Chief Medical Officer
- News
HEPTA Medical secures €5.7 million Series A, led by BPI France to advance minimally invasive lung cancer treatment
- News
Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas